22223-16-1 Usage
Uses
Used in Pharmaceutical Industry:
(5ξ,6ξ,7ξ,12ξ,19ξ)-2,3-Didehydro-6,7-epoxy-16-methoxyaspidospermidine-3-carboxylic acid methyl ester is used as a pharmaceutical candidate for its potential therapeutic properties. Its unique ketonic structure and complex molecular arrangement make it a promising compound for the development of new drugs and treatments.
Used in Chemical Research:
(5ξ,6ξ,7ξ,12ξ,19ξ)-2,3-Didehydro-6,7-epoxy-16-methoxyaspidospermidine-3-carboxylic acid methyl ester is used as a research compound in chemical studies. Its unique structure and properties provide valuable insights into the synthesis, reactivity, and potential applications of complex alkaloids.
Used in Drug Delivery Systems:
(5ξ,6ξ,7ξ,12ξ,19ξ)-2,3-Didehydro-6,7-epoxy-16-methoxyaspidospermidine-3-carboxylic acid methyl ester can be used as a component in drug delivery systems. Its unique structure and properties may allow for the development of novel drug carriers, improving the delivery, bioavailability, and therapeutic outcomes of various drugs.
References
Rakhimov et al., Khim. Prir. Soedin., 6, 226 (1970)
Check Digit Verification of cas no
The CAS Registry Mumber 22223-16-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,2,2 and 3 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 22223-16:
(7*2)+(6*2)+(5*2)+(4*2)+(3*3)+(2*1)+(1*6)=61
61 % 10 = 1
So 22223-16-1 is a valid CAS Registry Number.
22223-16-1Relevant academic research and scientific papers
Biotransformation of tabersonine in cell suspension cultures of Catharanthus roseus.
Furuya,Sakamoto,Iida,Asada,Yoshikawa,Sakai,Aimi
, p. 3065 - 3068 (2007/10/02)
To investigate the reactions involved in the biosynthesis of vindoline from tabersonine, the bioconversion products formed when the latter compound was fed to cell suspension cultures of Catharanthus roseus were isolated and characterized. Two biotransformation products of tabersonine were isolated and shown to be lochnericine, which is formed by epoxidation of tabersonine at positions 14, 15, and lochnerinine, the 11-methoxylation product of lochnericine. The bioconversion ratio of the main biotransformation product, lochnericine, reached a value of 80.6% within three days.
